Allianz has recommitted to the venture capital firm having funded its $170m debut vehicle two years ago.
AV8 Ventures, the US-headquartered venture capital firm backed by insurance group Allianz, launched a $180m second fund yesterday.
Formed in 2018, AV8 invests in healthcare, enterprise, financial and deep technology having emerged in April 2019 with a $170m fund for which Allianz supplied the entirety of the capital.
The firm has built a 22-strong portfolio which includes Delfi Diagonistics, the liquid biopsy technology developer that raised $100m in January this year, in addition to digital design assistant provider…
